ID záznamu: | 214247 |
Kategória: | ADC |
Autor: | Shore Neal (10%) |
Autor: | Minčík Ivan (10%) |
Autor: | DeGuenther Mark (8%) |
Autor: | Student Vladimir jr. (8%) |
Autor: | Jievaltas Mindaugas (8%) |
Autor: | Patočková Jitka (8%) |
Autor: | Simpson Kelle (8%) |
Autor: | Huang Shih-Tsung (8%) |
Autor: | Li Yuhua (8%) |
Autor: | Lee Yisheng (8%) |
Autor: | Chien Ben (8%) |
Autor: | Mao John (8%) |
Názov: | A phase 3, open-label, multicenter study of a 6-month pre-mixed depot formulation of leuprolide mesylate in advanced prostate cancer patients [print, elektronický dokument] |
Zdroj: | World Journal of Urology [print] |
Lokácia: | Roč. 38, č. 1. - Berlín, (2020), s. 111-119 |
ISSN: | 0724-4983. - ISSN 1433-8726 |
URL: | https://link.springer.com/journal/345/volumes-and-issues/38-1 |
Ohlas: | [1] 2021. ZHOU, H., XIE, J., ZHU, X. Pharmacokinetic and pharmacodynamic evaluation of the new prolonged-release leuprorelin acetate microspheres for injection compared with Enantone in healthy Chinese male volunteers. In Expert opinion on drug metabolism and toxicology, ISSN 1742-5255. 2021, vol. 17, no. 9, s. 1149-1156. WOS:000683613000001;SCOPUS. |
Oblasť výskumu: | 180 |